Study of Decitabine Combined With HAAG Regimen in Newly Diagnosed ETP-ALL/LBL, T/M-MPAL and ALL/LBL With Myeloid or Stem Cell Markers Patients

Name: Study of Decitabine Combined With HAAG Regimen in Newly Diagnosed ETP-ALL/LBL, T/M-MPAL and ALL/LBL With Myeloid or Stem Cell Markers Patients
Published: 2019
License: Public Domain

The First Affiliated Hospital of Soochow University · 2019

ClinicalTrials.gov · Datasets · License: Public Domain · 2019

Open Source ↗

induction chemotherapy, acute t-lymphocytic leukemia, t-cell lymphoblastic lymphoma leukemia, t-cell/myeloid mixed phenotype acute leukemia, t-all/lbl, t/m-mpal, decitabine combined with haag, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Study of Decitabine Combined With HAAG Regimen in Newly Diagnosed ETP-ALL/LBL, T/M-MPAL and ALL/LBL With Myeloid or Stem Cell Markers Patients

Related documents